| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromatin | 103 | 2025 | 599 | 15.620 |
Why?
|
| Chromosomes | 47 | 2025 | 135 | 12.290 |
Why?
|
| Chromatin Immunoprecipitation | 20 | 2019 | 145 | 6.320 |
Why?
|
| Genome | 27 | 2023 | 257 | 4.860 |
Why?
|
| Nucleic Acid Conformation | 32 | 2024 | 234 | 4.670 |
Why?
|
| DNA | 35 | 2024 | 806 | 4.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 22 | 2025 | 168 | 4.040 |
Why?
|
| Genome, Human | 20 | 2020 | 224 | 3.960 |
Why?
|
| Cell Nucleus | 20 | 2023 | 608 | 3.860 |
Why?
|
| Gene Library | 14 | 2018 | 98 | 3.830 |
Why?
|
| Chromosome Mapping | 23 | 2019 | 284 | 3.770 |
Why?
|
| Genomics | 27 | 2023 | 319 | 3.620 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 15 | 2023 | 96 | 3.040 |
Why?
|
| Chromosomes, Human | 10 | 2021 | 53 | 3.040 |
Why?
|
| Mitosis | 14 | 2025 | 208 | 2.770 |
Why?
|
| Cross-Linking Reagents | 12 | 2021 | 117 | 2.660 |
Why?
|
| Polymerase Chain Reaction | 14 | 2018 | 495 | 2.560 |
Why?
|
| Cell Cycle Proteins | 18 | 2025 | 384 | 2.550 |
Why?
|
| Gene Expression Regulation | 27 | 2023 | 1552 | 2.460 |
Why?
|
| Chromatids | 4 | 2025 | 15 | 2.390 |
Why?
|
| Chromosomes, Fungal | 12 | 2017 | 35 | 2.270 |
Why?
|
| DNA-Binding Proteins | 23 | 2025 | 1151 | 2.010 |
Why?
|
| Saccharomycetales | 4 | 2015 | 17 | 1.950 |
Why?
|
| Heterochromatin | 8 | 2023 | 84 | 1.800 |
Why?
|
| DNA Primers | 16 | 2018 | 289 | 1.760 |
Why?
|
| Sequence Analysis, DNA | 12 | 2018 | 394 | 1.740 |
Why?
|
| Interphase | 9 | 2025 | 68 | 1.730 |
Why?
|
| Saccharomyces cerevisiae | 14 | 2020 | 540 | 1.710 |
Why?
|
| Promoter Regions, Genetic | 20 | 2020 | 651 | 1.700 |
Why?
|
| Dinoflagellida | 3 | 2022 | 3 | 1.700 |
Why?
|
| CCCTC-Binding Factor | 15 | 2022 | 40 | 1.590 |
Why?
|
| Nucleosomes | 7 | 2023 | 184 | 1.590 |
Why?
|
| Animals | 86 | 2025 | 19651 | 1.570 |
Why?
|
| Enhancer Elements, Genetic | 15 | 2023 | 103 | 1.510 |
Why?
|
| DNA Topoisomerases, Type II | 4 | 2025 | 7 | 1.510 |
Why?
|
| Adenosine Triphosphatases | 9 | 2025 | 253 | 1.480 |
Why?
|
| Transcription, Genetic | 23 | 2023 | 844 | 1.470 |
Why?
|
| Multiprotein Complexes | 8 | 2025 | 153 | 1.460 |
Why?
|
| Genetic Techniques | 4 | 2021 | 39 | 1.450 |
Why?
|
| Formaldehyde | 10 | 2023 | 32 | 1.250 |
Why?
|
| Cell Compartmentation | 4 | 2021 | 35 | 1.190 |
Why?
|
| Molecular Sequence Annotation | 6 | 2020 | 61 | 1.170 |
Why?
|
| Repressor Proteins | 12 | 2017 | 332 | 1.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 191 | 1.140 |
Why?
|
| X Chromosome Inactivation | 6 | 2020 | 57 | 1.140 |
Why?
|
| Humans | 96 | 2025 | 59360 | 1.090 |
Why?
|
| Histones | 16 | 2023 | 458 | 1.050 |
Why?
|
| X Chromosome | 5 | 2020 | 44 | 1.030 |
Why?
|
| DNA Replication | 10 | 2024 | 228 | 0.980 |
Why?
|
| Anthozoa | 2 | 2022 | 4 | 0.960 |
Why?
|
| Chromosome Segregation | 3 | 2024 | 39 | 0.950 |
Why?
|
| Models, Molecular | 9 | 2017 | 1128 | 0.940 |
Why?
|
| Encyclopedias as Topic | 3 | 2012 | 5 | 0.910 |
Why?
|
| Translocation, Genetic | 5 | 2024 | 63 | 0.890 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2018 | 294 | 0.880 |
Why?
|
| Cell Line | 21 | 2021 | 1984 | 0.880 |
Why?
|
| High-Throughput Nucleotide Sequencing | 11 | 2021 | 263 | 0.880 |
Why?
|
| Molecular Conformation | 8 | 2015 | 133 | 0.860 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2016 | 74 | 0.820 |
Why?
|
| Regulatory Elements, Transcriptional | 4 | 2013 | 37 | 0.810 |
Why?
|
| Microalgae | 1 | 2021 | 5 | 0.760 |
Why?
|
| Nuclear Proteins | 11 | 2021 | 750 | 0.760 |
Why?
|
| Chromosomes, Mammalian | 4 | 2020 | 33 | 0.730 |
Why?
|
| Cell Cycle | 5 | 2019 | 382 | 0.720 |
Why?
|
| Models, Biological | 13 | 2021 | 1143 | 0.720 |
Why?
|
| Mice | 36 | 2023 | 10292 | 0.700 |
Why?
|
| Epigenesis, Genetic | 6 | 2020 | 357 | 0.700 |
Why?
|
| HeLa Cells | 6 | 2020 | 526 | 0.670 |
Why?
|
| Telophase | 1 | 2019 | 5 | 0.670 |
Why?
|
| Chromatin Assembly and Disassembly | 9 | 2023 | 229 | 0.660 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2018 | 54 | 0.650 |
Why?
|
| Transcription Factors | 14 | 2022 | 1471 | 0.610 |
Why?
|
| Binding Sites | 13 | 2020 | 881 | 0.600 |
Why?
|
| Software | 6 | 2019 | 367 | 0.600 |
Why?
|
| Embryonic Stem Cells | 11 | 2021 | 151 | 0.600 |
Why?
|
| Carcinogenesis | 2 | 2016 | 118 | 0.590 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2017 | 11 | 0.570 |
Why?
|
| Data Interpretation, Statistical | 3 | 2018 | 191 | 0.570 |
Why?
|
| Algorithms | 4 | 2015 | 976 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 475 | 0.560 |
Why?
|
| Molecular Imaging | 1 | 2017 | 46 | 0.550 |
Why?
|
| DNA Repair | 4 | 2023 | 242 | 0.540 |
Why?
|
| Globins | 6 | 2018 | 25 | 0.530 |
Why?
|
| DNA Methylation | 7 | 2020 | 271 | 0.510 |
Why?
|
| Cells, Cultured | 13 | 2020 | 2093 | 0.510 |
Why?
|
| Silencer Elements, Transcriptional | 2 | 2019 | 3 | 0.490 |
Why?
|
| RNA-Binding Proteins | 5 | 2021 | 386 | 0.490 |
Why?
|
| Multigene Family | 5 | 2017 | 92 | 0.480 |
Why?
|
| Protein Binding | 14 | 2018 | 1557 | 0.480 |
Why?
|
| Databases, Nucleic Acid | 2 | 2012 | 8 | 0.470 |
Why?
|
| Proteins | 2 | 2018 | 730 | 0.460 |
Why?
|
| Alleles | 6 | 2023 | 411 | 0.460 |
Why?
|
| Gene Silencing | 5 | 2020 | 378 | 0.460 |
Why?
|
| Base Composition | 2 | 2021 | 27 | 0.460 |
Why?
|
| Contig Mapping | 1 | 2013 | 3 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2013 | 27 | 0.440 |
Why?
|
| Gene Frequency | 1 | 2013 | 118 | 0.430 |
Why?
|
| Genetic Loci | 4 | 2018 | 107 | 0.430 |
Why?
|
| Telomere | 4 | 2021 | 50 | 0.430 |
Why?
|
| Models, Genetic | 6 | 2017 | 255 | 0.420 |
Why?
|
| Genome, Fungal | 4 | 2017 | 40 | 0.420 |
Why?
|
| Phosphoproteins | 3 | 2013 | 211 | 0.420 |
Why?
|
| Neoplasms | 5 | 2024 | 1240 | 0.420 |
Why?
|
| Histone Code | 4 | 2023 | 26 | 0.420 |
Why?
|
| DNA Replication Timing | 4 | 2020 | 16 | 0.410 |
Why?
|
| Epistasis, Genetic | 4 | 2013 | 42 | 0.400 |
Why?
|
| Drosophila melanogaster | 4 | 2019 | 481 | 0.400 |
Why?
|
| DNA Breaks, Double-Stranded | 4 | 2023 | 78 | 0.390 |
Why?
|
| Cadherins | 1 | 2012 | 69 | 0.390 |
Why?
|
| K562 Cells | 5 | 2021 | 57 | 0.390 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2024 | 119 | 0.380 |
Why?
|
| Cell Differentiation | 8 | 2021 | 1304 | 0.370 |
Why?
|
| RNA | 4 | 2023 | 401 | 0.360 |
Why?
|
| Internet | 3 | 2012 | 448 | 0.340 |
Why?
|
| Single-Cell Analysis | 4 | 2023 | 91 | 0.340 |
Why?
|
| Sequence Deletion | 6 | 2017 | 112 | 0.340 |
Why?
|
| Genomic Structural Variation | 2 | 2021 | 4 | 0.340 |
Why?
|
| Methylation | 6 | 2022 | 124 | 0.340 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2017 | 425 | 0.340 |
Why?
|
| Meiosis | 4 | 2010 | 62 | 0.340 |
Why?
|
| Chromosome Pairing | 2 | 2019 | 5 | 0.330 |
Why?
|
| Chromosomes, Insect | 2 | 2019 | 8 | 0.330 |
Why?
|
| Replication Origin | 5 | 2022 | 35 | 0.330 |
Why?
|
| Genome, Insect | 2 | 2019 | 31 | 0.330 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 166 | 0.330 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2009 | 6 | 0.320 |
Why?
|
| Neural Stem Cells | 4 | 2017 | 43 | 0.320 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2009 | 14 | 0.320 |
Why?
|
| Fibroblasts | 8 | 2020 | 377 | 0.320 |
Why?
|
| User-Computer Interface | 1 | 2009 | 123 | 0.310 |
Why?
|
| Base Sequence | 9 | 2018 | 1302 | 0.310 |
Why?
|
| RNA, Untranslated | 5 | 2018 | 101 | 0.310 |
Why?
|
| Prometaphase | 2 | 2019 | 6 | 0.310 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 62 | 0.300 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 2018 | 16 | 0.300 |
Why?
|
| DNA Restriction Enzymes | 3 | 2023 | 35 | 0.300 |
Why?
|
| Genome Components | 2 | 2019 | 5 | 0.300 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2018 | 19 | 0.290 |
Why?
|
| Cellular Reprogramming | 2 | 2019 | 35 | 0.290 |
Why?
|
| G1 Phase | 2 | 2012 | 55 | 0.290 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 1118 | 0.290 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2018 | 619 | 0.280 |
Why?
|
| Schizosaccharomyces pombe Proteins | 3 | 2017 | 73 | 0.280 |
Why?
|
| Xenopus laevis | 4 | 2023 | 67 | 0.280 |
Why?
|
| Drosophila Proteins | 4 | 2019 | 679 | 0.280 |
Why?
|
| Adenoviridae | 2 | 1998 | 117 | 0.280 |
Why?
|
| Molecular Biology | 1 | 2007 | 66 | 0.270 |
Why?
|
| Transcriptional Activation | 4 | 2019 | 188 | 0.260 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2021 | 75 | 0.260 |
Why?
|
| Antibodies | 2 | 2018 | 179 | 0.260 |
Why?
|
| Gene Regulatory Networks | 3 | 2012 | 147 | 0.260 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2006 | 38 | 0.250 |
Why?
|
| Computational Biology | 4 | 2019 | 333 | 0.250 |
Why?
|
| Cell Lineage | 5 | 2023 | 259 | 0.250 |
Why?
|
| Viral Proteins | 2 | 1998 | 253 | 0.250 |
Why?
|
| Cell Line, Transformed | 2 | 2019 | 98 | 0.250 |
Why?
|
| Quality Control | 2 | 2019 | 71 | 0.250 |
Why?
|
| Tretinoin | 1 | 2025 | 49 | 0.240 |
Why?
|
| Genes, Homeobox | 2 | 2017 | 23 | 0.240 |
Why?
|
| Symbiosis | 2 | 2022 | 29 | 0.240 |
Why?
|
| Gene Expression | 3 | 2019 | 809 | 0.230 |
Why?
|
| Cell Nucleolus | 3 | 2015 | 68 | 0.230 |
Why?
|
| In Situ Hybridization, Fluorescence | 7 | 2015 | 152 | 0.230 |
Why?
|
| Thymocytes | 2 | 2015 | 19 | 0.230 |
Why?
|
| Protein Conformation | 5 | 2009 | 763 | 0.230 |
Why?
|
| Protein Domains | 4 | 2020 | 140 | 0.230 |
Why?
|
| B-Lymphocytes | 3 | 2019 | 550 | 0.220 |
Why?
|
| Actins | 2 | 2022 | 259 | 0.220 |
Why?
|
| Receptors, Odorant | 1 | 2023 | 5 | 0.220 |
Why?
|
| Polymers | 2 | 2024 | 316 | 0.220 |
Why?
|
| S Phase | 3 | 2022 | 74 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 275 | 0.220 |
Why?
|
| Biological Evolution | 2 | 2023 | 114 | 0.220 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2023 | 13 | 0.220 |
Why?
|
| Estrogen Receptor alpha | 1 | 2023 | 45 | 0.220 |
Why?
|
| Chromosomes, Bacterial | 2 | 2015 | 41 | 0.220 |
Why?
|
| Mutation | 6 | 2021 | 2456 | 0.220 |
Why?
|
| Aneuploidy | 1 | 2024 | 40 | 0.210 |
Why?
|
| Benzimidazoles | 2 | 2021 | 56 | 0.210 |
Why?
|
| Animal Fins | 1 | 2023 | 3 | 0.210 |
Why?
|
| Cell Line, Tumor | 7 | 2025 | 1370 | 0.210 |
Why?
|
| Gene Dosage | 2 | 2021 | 60 | 0.210 |
Why?
|
| Prophase | 2 | 2025 | 15 | 0.210 |
Why?
|
| Male | 18 | 2023 | 27739 | 0.210 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2021 | 75 | 0.210 |
Why?
|
| DNA Cleavage | 2 | 2012 | 18 | 0.200 |
Why?
|
| Temperature | 2 | 2018 | 295 | 0.200 |
Why?
|
| DNA Damage | 3 | 2022 | 279 | 0.200 |
Why?
|
| Female | 19 | 2024 | 30705 | 0.200 |
Why?
|
| Fixatives | 2 | 2012 | 17 | 0.200 |
Why?
|
| DNA, Viral | 3 | 1998 | 223 | 0.200 |
Why?
|
| Transcription Initiation Site | 3 | 2019 | 49 | 0.200 |
Why?
|
| Caenorhabditis | 1 | 2022 | 14 | 0.200 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 1561 | 0.200 |
Why?
|
| RNA, Long Noncoding | 4 | 2020 | 152 | 0.190 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2021 | 6 | 0.190 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2021 | 14 | 0.190 |
Why?
|
| Coral Reefs | 1 | 2021 | 1 | 0.190 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2011 | 65 | 0.190 |
Why?
|
| Spermatozoa | 1 | 2023 | 253 | 0.190 |
Why?
|
| Drosophila | 2 | 2019 | 421 | 0.190 |
Why?
|
| Ribonucleoproteins | 2 | 2022 | 112 | 0.190 |
Why?
|
| High-Throughput Screening Assays | 2 | 2012 | 74 | 0.190 |
Why?
|
| Genomic Instability | 2 | 2023 | 53 | 0.190 |
Why?
|
| Phenanthrenes | 1 | 2021 | 7 | 0.190 |
Why?
|
| Fishes | 1 | 2021 | 19 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 167 | 0.180 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2021 | 35 | 0.180 |
Why?
|
| Diterpenes | 1 | 2021 | 19 | 0.180 |
Why?
|
| Epoxy Compounds | 1 | 2021 | 9 | 0.180 |
Why?
|
| DNA, Fungal | 2 | 2020 | 57 | 0.180 |
Why?
|
| Exons | 4 | 2019 | 191 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 676 | 0.180 |
Why?
|
| Half-Life | 1 | 2021 | 76 | 0.180 |
Why?
|
| Schizosaccharomyces | 3 | 2020 | 104 | 0.180 |
Why?
|
| Epithelial Cells | 3 | 2024 | 391 | 0.180 |
Why?
|
| Systems Biology | 2 | 2018 | 29 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2024 | 942 | 0.180 |
Why?
|
| Polycomb Repressive Complex 1 | 2 | 2018 | 31 | 0.170 |
Why?
|
| Genes | 3 | 2011 | 90 | 0.170 |
Why?
|
| Genetic Variation | 4 | 2021 | 357 | 0.170 |
Why?
|
| DNA Footprinting | 3 | 2020 | 17 | 0.170 |
Why?
|
| Deoxyribonuclease I | 3 | 2020 | 40 | 0.170 |
Why?
|
| Chromosome Structures | 2 | 2017 | 7 | 0.170 |
Why?
|
| Cell Communication | 1 | 2020 | 124 | 0.170 |
Why?
|
| Databases, Genetic | 1 | 2020 | 83 | 0.170 |
Why?
|
| Genome-Wide Association Study | 4 | 2016 | 331 | 0.170 |
Why?
|
| DNA Helicases | 3 | 2018 | 187 | 0.170 |
Why?
|
| Nuclear Lamina | 2 | 2019 | 11 | 0.170 |
Why?
|
| Melanoma | 1 | 2023 | 329 | 0.170 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 11 | 0.160 |
Why?
|
| Cytokinesis | 1 | 2019 | 39 | 0.160 |
Why?
|
| Hematopoiesis | 1 | 2019 | 120 | 0.160 |
Why?
|
| Kinetics | 1 | 2021 | 751 | 0.160 |
Why?
|
| Nucleotide Motifs | 1 | 2019 | 50 | 0.150 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2015 | 22 | 0.150 |
Why?
|
| Sonication | 1 | 2018 | 15 | 0.150 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 25 | 0.150 |
Why?
|
| RNA Precursors | 1 | 2018 | 74 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2021 | 813 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 3231 | 0.150 |
Why?
|
| Locus Control Region | 3 | 2008 | 5 | 0.150 |
Why?
|
| RNA, Transfer | 2 | 2015 | 78 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 276 | 0.150 |
Why?
|
| Hot Temperature | 1 | 2018 | 126 | 0.150 |
Why?
|
| Mammals | 3 | 2020 | 209 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 96 | 0.140 |
Why?
|
| Cattle | 1 | 2018 | 304 | 0.140 |
Why?
|
| Stem Cells | 1 | 2019 | 255 | 0.140 |
Why?
|
| Caenorhabditis elegans | 4 | 2022 | 623 | 0.140 |
Why?
|
| Polycomb-Group Proteins | 3 | 2019 | 21 | 0.140 |
Why?
|
| Goals | 1 | 2017 | 88 | 0.140 |
Why?
|
| Registries | 1 | 2020 | 801 | 0.130 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 9 | 0.130 |
Why?
|
| Sequence Analysis | 1 | 2016 | 11 | 0.130 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 39 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 27 | 0.130 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 196 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2017 | 111 | 0.130 |
Why?
|
| Staining and Labeling | 1 | 2017 | 124 | 0.130 |
Why?
|
| Proteomics | 1 | 2018 | 263 | 0.130 |
Why?
|
| Proto-Oncogenes | 1 | 2016 | 8 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 718 | 0.130 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 46 | 0.130 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 62 | 0.130 |
Why?
|
| Precursor Cells, B-Lymphoid | 2 | 2013 | 8 | 0.130 |
Why?
|
| Tissue Fixation | 2 | 2012 | 21 | 0.130 |
Why?
|
| Conserved Sequence | 3 | 2011 | 170 | 0.120 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2015 | 11 | 0.120 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 49 | 0.120 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 32 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 111 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1465 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 2 | 2015 | 159 | 0.120 |
Why?
|
| Yeasts | 1 | 2015 | 51 | 0.120 |
Why?
|
| Carbon | 1 | 2015 | 45 | 0.120 |
Why?
|
| Time Factors | 3 | 2019 | 3617 | 0.120 |
Why?
|
| Restriction Mapping | 2 | 2012 | 51 | 0.120 |
Why?
|
| Biotin | 2 | 2017 | 51 | 0.120 |
Why?
|
| Mice, Transgenic | 4 | 2021 | 1206 | 0.120 |
Why?
|
| Biochemistry | 1 | 2015 | 50 | 0.110 |
Why?
|
| Mediator Complex | 2 | 2013 | 13 | 0.110 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 1952 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 439 | 0.110 |
Why?
|
| Fungal Proteins | 2 | 2008 | 144 | 0.110 |
Why?
|
| VDJ Exons | 1 | 2013 | 1 | 0.110 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2013 | 24 | 0.110 |
Why?
|
| Metaphase | 1 | 2013 | 34 | 0.110 |
Why?
|
| Homeodomain Proteins | 3 | 2023 | 255 | 0.110 |
Why?
|
| Human Genome Project | 1 | 2013 | 4 | 0.110 |
Why?
|
| Evolution, Molecular | 4 | 2024 | 298 | 0.110 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2015 | 397 | 0.110 |
Why?
|
| DNA End-Joining Repair | 2 | 2023 | 23 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2013 | 136 | 0.100 |
Why?
|
| Lamins | 1 | 2012 | 5 | 0.100 |
Why?
|
| Progeria | 1 | 2012 | 4 | 0.100 |
Why?
|
| Apoptosis | 1 | 2018 | 1032 | 0.100 |
Why?
|
| Centromere | 3 | 2015 | 38 | 0.100 |
Why?
|
| Biopolymers | 1 | 2013 | 69 | 0.100 |
Why?
|
| DNA Ligases | 1 | 2012 | 4 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 108 | 0.100 |
Why?
|
| Embryo, Mammalian | 3 | 2020 | 156 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 35 | 0.100 |
Why?
|
| Asthma | 1 | 2016 | 453 | 0.100 |
Why?
|
| DNA, Single-Stranded | 3 | 2017 | 100 | 0.100 |
Why?
|
| Receptors, Antigen | 1 | 2012 | 7 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 37 | 0.100 |
Why?
|
| Arabidopsis Proteins | 1 | 2012 | 41 | 0.100 |
Why?
|
| Organ Specificity | 3 | 2024 | 183 | 0.100 |
Why?
|
| Transcriptome | 2 | 2012 | 340 | 0.100 |
Why?
|
| Cells | 1 | 2012 | 31 | 0.090 |
Why?
|
| Lung | 1 | 2016 | 919 | 0.090 |
Why?
|
| Arabidopsis | 1 | 2012 | 80 | 0.090 |
Why?
|
| Gene Components | 1 | 2011 | 5 | 0.090 |
Why?
|
| Spindle Apparatus | 2 | 2023 | 123 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2011 | 61 | 0.090 |
Why?
|
| Caulobacter crescentus | 1 | 2011 | 34 | 0.090 |
Why?
|
| Crossing Over, Genetic | 1 | 2010 | 3 | 0.090 |
Why?
|
| alpha-Globins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Microarray Analysis | 2 | 2012 | 60 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2010 | 25 | 0.090 |
Why?
|
| Templates, Genetic | 2 | 2007 | 21 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2016 | 689 | 0.090 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2010 | 36 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 33 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 868 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 56 | 0.080 |
Why?
|
| Blepharophimosis | 1 | 2009 | 2 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2019 | 111 | 0.080 |
Why?
|
| Insulator Elements | 1 | 2009 | 4 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 87 | 0.080 |
Why?
|
| 5' Untranslated Regions | 1 | 2009 | 24 | 0.080 |
Why?
|
| Genes, Fungal | 1 | 2009 | 56 | 0.080 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 88 | 0.080 |
Why?
|
| Normal Distribution | 1 | 2008 | 17 | 0.080 |
Why?
|
| Linkage Disequilibrium | 2 | 2018 | 46 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 125 | 0.080 |
Why?
|
| Cell Culture Techniques | 2 | 2019 | 178 | 0.080 |
Why?
|
| Ikaros Transcription Factor | 1 | 2008 | 3 | 0.070 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2008 | 9 | 0.070 |
Why?
|
| Genes, Switch | 1 | 2008 | 6 | 0.070 |
Why?
|
| PAX5 Transcription Factor | 2 | 2019 | 12 | 0.070 |
Why?
|
| Response Elements | 1 | 2007 | 43 | 0.070 |
Why?
|
| Datasets as Topic | 2 | 2019 | 24 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2008 | 298 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 657 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2008 | 256 | 0.070 |
Why?
|
| DNA, Ribosomal | 2 | 2017 | 29 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 103 | 0.070 |
Why?
|
| Epigenomics | 2 | 2020 | 54 | 0.070 |
Why?
|
| Biological Assay | 1 | 2006 | 56 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 210 | 0.060 |
Why?
|
| MCF-7 Cells | 2 | 2016 | 65 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2007 | 125 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 365 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 1998 | 289 | 0.060 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2025 | 9 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2018 | 587 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 2005 | 28 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2021 | 297 | 0.060 |
Why?
|
| Point Mutation | 2 | 2019 | 160 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 65 | 0.050 |
Why?
|
| Uveal Neoplasms | 1 | 2023 | 52 | 0.050 |
Why?
|
| Tripartite Motif Proteins | 1 | 2023 | 39 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2024 | 101 | 0.050 |
Why?
|
| United States | 1 | 2016 | 7390 | 0.050 |
Why?
|
| Cell Size | 1 | 2023 | 40 | 0.050 |
Why?
|
| Progesterone | 1 | 2023 | 158 | 0.050 |
Why?
|
| Polymerization | 1 | 2022 | 34 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 133 | 0.050 |
Why?
|
| Melanocytes | 1 | 2023 | 78 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2050 | 0.050 |
Why?
|
| Estradiol | 1 | 2023 | 247 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2023 | 241 | 0.050 |
Why?
|
| Nitrogen | 1 | 2022 | 24 | 0.050 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 2002 | 2 | 0.050 |
Why?
|
| GC Rich Sequence | 1 | 2002 | 3 | 0.050 |
Why?
|
| AT Rich Sequence | 1 | 2002 | 5 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2017 | 458 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2002 | 32 | 0.050 |
Why?
|
| Mathematics | 1 | 2002 | 32 | 0.050 |
Why?
|
| Ecosystem | 1 | 2022 | 38 | 0.050 |
Why?
|
| Erythroid Cells | 1 | 2021 | 9 | 0.050 |
Why?
|
| Eukaryota | 1 | 2022 | 29 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2023 | 270 | 0.050 |
Why?
|
| DNA, Intergenic | 2 | 2012 | 23 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2021 | 25 | 0.050 |
Why?
|
| Oryzias | 1 | 2021 | 5 | 0.050 |
Why?
|
| Synteny | 1 | 2021 | 23 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 194 | 0.050 |
Why?
|
| Phthalazines | 1 | 2021 | 2 | 0.050 |
Why?
|
| U937 Cells | 1 | 2021 | 8 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2021 | 19 | 0.040 |
Why?
|
| beta-Globins | 1 | 2020 | 9 | 0.040 |
Why?
|
| Transposases | 1 | 2020 | 14 | 0.040 |
Why?
|
| DNA, Recombinant | 1 | 2020 | 44 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2020 | 95 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 178 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 857 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2005 | 697 | 0.040 |
Why?
|
| Esterases | 1 | 2000 | 13 | 0.040 |
Why?
|
| Zebrafish | 1 | 2023 | 326 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 55 | 0.040 |
Why?
|
| Oocytes | 1 | 2021 | 193 | 0.040 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2019 | 3 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 245 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 513 | 0.040 |
Why?
|
| Zygote | 1 | 2019 | 44 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 516 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2019 | 850 | 0.040 |
Why?
|
| Euchromatin | 1 | 2019 | 16 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2016 | 293 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 70 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 169 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 280 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 36 | 0.040 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 24 | 0.040 |
Why?
|
| Systems Integration | 1 | 2018 | 26 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 675 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 52 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 113 | 0.040 |
Why?
|
| Azepines | 1 | 2018 | 19 | 0.040 |
Why?
|
| Chromosome Inversion | 1 | 2018 | 17 | 0.040 |
Why?
|
| Multifunctional Enzymes | 1 | 2018 | 17 | 0.040 |
Why?
|
| Spliceosomes | 1 | 2018 | 41 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 450 | 0.040 |
Why?
|
| Triazoles | 1 | 2018 | 51 | 0.040 |
Why?
|
| RNA Stability | 1 | 2018 | 97 | 0.040 |
Why?
|
| Limb Buds | 1 | 2017 | 1 | 0.040 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 82 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 211 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2018 | 77 | 0.040 |
Why?
|
| Endonucleases | 1 | 2018 | 80 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2019 | 300 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2018 | 159 | 0.040 |
Why?
|
| Spodoptera | 1 | 1997 | 27 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 38 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2017 | 25 | 0.030 |
Why?
|
| Baculoviridae | 1 | 1997 | 26 | 0.030 |
Why?
|
| Proteome | 1 | 2018 | 141 | 0.030 |
Why?
|
| Indoleacetic Acids | 1 | 2017 | 31 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 396 | 0.030 |
Why?
|
| Netherlands | 1 | 2016 | 22 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 258 | 0.030 |
Why?
|
| Inverted Repeat Sequences | 1 | 2016 | 14 | 0.030 |
Why?
|
| NFI Transcription Factors | 1 | 1996 | 7 | 0.030 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 1996 | 6 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1994 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 106 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1996 | 46 | 0.030 |
Why?
|
| Body Patterning | 1 | 2016 | 80 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 1998 | 113 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2016 | 100 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 83 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 193 | 0.030 |
Why?
|
| Clone Cells | 1 | 2016 | 106 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1997 | 374 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 288 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2016 | 253 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2016 | 169 | 0.030 |
Why?
|
| Cytogenetic Analysis | 1 | 2015 | 23 | 0.030 |
Why?
|
| DNA Primase | 1 | 2015 | 4 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 132 | 0.030 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 53 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 424 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 243 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 333 | 0.030 |
Why?
|
| Virus Replication | 1 | 1996 | 305 | 0.030 |
Why?
|
| Protein Folding | 1 | 1996 | 260 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 139 | 0.030 |
Why?
|
| Disease | 1 | 2014 | 25 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 259 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 1554 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1189 | 0.030 |
Why?
|
| Titrimetry | 1 | 2012 | 11 | 0.030 |
Why?
|
| Data Display | 1 | 2012 | 6 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2012 | 16 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2012 | 19 | 0.030 |
Why?
|
| Rats | 1 | 1996 | 1910 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 402 | 0.020 |
Why?
|
| Genes, Plant | 1 | 2012 | 20 | 0.020 |
Why?
|
| Chimerin Proteins | 1 | 2012 | 1 | 0.020 |
Why?
|
| RNA Isoforms | 1 | 2012 | 3 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 21 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 19 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2012 | 27 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2016 | 695 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 1782 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 177 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2012 | 127 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 29 | 0.020 |
Why?
|
| Sister Chromatid Exchange | 1 | 2010 | 1 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 365 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 75 | 0.020 |
Why?
|
| Africa | 1 | 2010 | 21 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Chromosome Positioning | 1 | 2010 | 5 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 18 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 192 | 0.020 |
Why?
|
| Adult | 1 | 2006 | 15669 | 0.020 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Telomere-Binding Proteins | 1 | 2009 | 6 | 0.020 |
Why?
|
| Telomerase | 1 | 2009 | 31 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 188 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 327 | 0.020 |
Why?
|
| Microscopy | 1 | 2009 | 90 | 0.020 |
Why?
|
| Fetal Hemoglobin | 1 | 2008 | 12 | 0.020 |
Why?
|
| Child | 1 | 2016 | 4174 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 590 | 0.020 |
Why?
|
| Heterozygote | 1 | 2007 | 161 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 527 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1486 | 0.020 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 3 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2005 | 7 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2005 | 72 | 0.010 |
Why?
|
| DNA, Plant | 1 | 2004 | 7 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 110 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 914 | 0.010 |
Why?
|
| Endodeoxyribonucleases | 1 | 2000 | 41 | 0.010 |
Why?
|